Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 142.75
+1.15 (0.81%)
At close: Jun 19, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 428.25 million as of June 18, 2026. Its market cap has decreased by -23.19% in one year.
Market Cap
428.25M
Enterprise Value
417.79M
Revenue
266.14M
Ranking
n/a
PE Ratio
19.24
Stock Price
142.75
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 428.25M, an increase of 1,271.28%. That is a compound annual growth rate of 21.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 428.25M | 26.95% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.53B |
| Krebs Biochemicals & Industries | 1.40B |
| Smruthi Organics | 1.36B |
| Tyche Industries | 1.34B |
| Bacil Pharma | 581.87M |
| Vasundhara Rasayans | 540.93M |
| Alfavision Overseas (India) | 259.77M |
| Venmax Drugs and Pharmaceuticals | 230.15M |